These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11851748)

  • 1. Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation.
    Houltram J; Noble I; Boyd RN; Corry I; Flett P; Graham HK
    Eur J Neurol; 2001 Nov; 8 Suppl 5():194-202. PubMed ID: 11851748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Controlled Trial on Effectiveness of Intermittent Serial Casting on Spastic Equinus Foot in Children with Cerebral Palsy After Botulinum Toxin-A Treatment.
    Dursun N; Gokbel T; Akarsu M; Dursun E
    Am J Phys Med Rehabil; 2017 Apr; 96(4):221-225. PubMed ID: 27631386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.
    Kay RM; Rethlefsen SA; Fern-Buneo A; Wren TA; Skaggs DL
    J Bone Joint Surg Am; 2004 Nov; 86(11):2377-84. PubMed ID: 15523006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the effects of casting on equinus in children with cerebral palsy: an evidence report of the AACPDM.
    Blackmore AM; Boettcher-Hunt E; Jordan M; Chan MD
    Dev Med Child Neurol; 2007 Oct; 49(10):781-90. PubMed ID: 17880650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
    Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.
    Koman LA; Brashear A; Rosenfeld S; Chambers H; Russman B; Rang M; Root L; Ferrari E; Garcia de Yebenes Prous J; Smith BP; Turkel C; Walcott JM; Molloy PT
    Pediatrics; 2001 Nov; 108(5):1062-71. PubMed ID: 11694682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option.
    Kirschner J; Berweck S; Mall V; Korinthenberg R; Heinen F
    J Neurol; 2001 Apr; 248 Suppl 1():28-30. PubMed ID: 11357236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: a retrospective analysis.
    Glanzman AM; Kim H; Swaminathan K; Beck T
    Dev Med Child Neurol; 2004 Dec; 46(12):807-11. PubMed ID: 15581153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunct therapies to improve outcomes after botulinum toxin injection in children: A systematic review.
    Mathevon L; Bonan I; Barnais JL; Boyer F; Dinomais M
    Ann Phys Rehabil Med; 2019 Jul; 62(4):283-290. PubMed ID: 30063979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of combined serial casting and botulinum toxin injection for spastic equinus in ambulatory children with cerebral palsy.
    Park ES; Rha DW; Yoo JK; Kim SM; Chang WH; Song SH
    Yonsei Med J; 2010 Jul; 51(4):579-84. PubMed ID: 20499426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
    Mousny M; Allington N
    Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.
    Linder M; Schindler G; Michaelis U; Stein S; Kirschner J; Mall V; Berweck S; Korinthenberg R; Heinen F
    Eur J Neurol; 2001 Nov; 8 Suppl 5():120-6. PubMed ID: 11851740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus.
    Newman CJ; Kennedy A; Walsh M; O'Brien T; Lynch B; Hensey O
    J Pediatr Orthop; 2007 Dec; 27(8):882-5. PubMed ID: 18209608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based approach of the use of Botulinum toxin type A (BTX) in cerebral palsy.
    Wong V
    Pediatr Rehabil; 2003; 6(2):85-96. PubMed ID: 14534045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
    Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
    Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based Recommendations for Pediatric Orthopaedic Practice.
    Mulpuri K; Schaeffer EK; Sanders J; Zaltz I; Kocher MS
    J Pediatr Orthop; 2018 Oct; 38(9):e551-e555. PubMed ID: 30074590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment.
    Bottos M; Benedetti MG; Salucci P; Gasparroni V; Giannini S
    Dev Med Child Neurol; 2003 Nov; 45(11):758-62. PubMed ID: 14580131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy.
    Ackman JD; Russman BS; Thomas SS; Buckon CE; Sussman MD; Masso P; Sanders J; D'Astous J; Aiona MD;
    Dev Med Child Neurol; 2005 Sep; 47(9):620-7. PubMed ID: 16138670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy.
    Graham HK; Aoki KR; Autti-Rämö I; Boyd RN; Delgado MR; Gaebler-Spira DJ; Gormley ME; Guyer BM; Heinen F; Holton AF; Matthews D; Molenaers G; Motta F; García Ruiz PJ; Wissel J
    Gait Posture; 2000 Feb; 11(1):67-79. PubMed ID: 10664488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
    Koman LA; Mooney JF; Smith BP; Walker F; Leon JM
    J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.